A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

被引：87

作者：

Chen, A. C. ^{[1
,2
]}

Martin, A. J. ^{[3
]}

Dalziell, R. A. ^{[1
]}

Mckenzie, C. A. ^{[4
]}

Lowe, P. M. ^{[2
,5
]}

Eris, J. M. ^{[2
,6
]}

Scolyer, R. A. ^{[2
,4
,7
]}

Dhillon, H. M. ^{[8
]}

Vardy, J. L. ^{[8
,9
,10
]}

Bielski, V. A. ^{[6
]}

Halliday, G. M. ^{[1
,2
]}

Damian, D. L. ^{[1
,2
,7
]}

机构：

[1] Univ Sydney, Dermatol & Bosch Inst, Royal Prince Alfred Hosp, Camperdown, NSW, Australia

[2] Univ Sydney, Sydney Med Sch, Cent Clin Sch, Sydney, NSW, Australia

[3] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia

[4] Royal Prince Alfred Hosp, Tissue Pathol & Diagnost Oncol, Sydney, NSW, Australia

[5] Royal Prince Alfred Hosp, Dept Dermatol, Sydney, NSW, Australia

[6] Royal Prince Alfred Hosp, Renal Med, Sydney, NSW, Australia

[7] Melanoma Inst Australia, Sydney, NSW, Australia

[8] Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making, Sydney, NSW, Australia

[9] Univ Sydney, Sydney Med Sch, Concord Clin Sch, Sydney, NSW, Australia

[10] Concord Repatriat Gen Hosp, Sydney, NSW, Australia

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2016年 / 175卷 / 05期

关键词：

RETINOIDS;

D O I：

10.1111/bjd.14662

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1073 / 1075

页数：3

共 11 条

[1] Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how [J].

Bettoli, Vincenzo ;

Zauli, Stefania ;

Virgili, Anna .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2013, 24 (03) :235-237

[2] A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention [J].

Chen, Andrew C. ;

Martin, Andrew J. ;

Choy, Bonita ;

Fernandez-Penas, Pablo ;

Dalziell, Robyn A. ;

McKenzie, Catriona A. ;

Scolyer, Richard A. ;

Dhillon, Haryana M. ;

Vardy, Janette L. ;

Kricker, Anne ;

St George, Gayathri ;

Chinniah, Niranthari ;

Halliday, Gary M. ;

Damian, Diona L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1618-1626

[3] Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials [J].

Chen, K ;

Craig, JC ;

Shumack, S .

BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (03) :518-523

[4] Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing [J].

Feldmeyer, L. ;

Hofbauer, G. F. L. ;

Boeni, T. ;

French, L. E. ;

Hafner, J. .

BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (02) :422-424

[5] Safety of high dose nicotinamide: a review [J].

Knip, M ;

Douek, IF ;

Moore, WPT ;

Gillmor, HA ;

McLean, AEM ;

Bingley, PJ ;

Gale, EAM .

DIABETOLOGIA, 2000, 43 (11) :1337-1345

[6]

LeBoit P.E., 2006, World Health Organization Classification of Tumours

[7] A population-based study of skin cancer incidence and prevalence in renal transplant recipients [J].

Moloney, FJ ;

Comber, H ;

O'Lorcain, P ;

O'Kelly, P ;

Conlon, PJ ;

Murphy, GM .

BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (03) :498-504

[8] Skin cancer in Australian heart transplant recipients [J].

Ong, CS ;

Keogh, AM ;

Kossard, S ;

Macdonald, PS ;

Spratt, PM .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (01) :27-34

[9] Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin [J].

Surjana, Devita ;

Halliday, Gary M. ;

Damian, Diona L. .

CARCINOGENESIS, 2013, 34 (05) :1144-1149

[10] Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in primary melanocytes [J].

Thompson, Benjamin C. ;

Surjana, Devita ;

Halliday, Gary M. ;

Damian, Diona L. .

EXPERIMENTAL DERMATOLOGY, 2014, 23 (07) :509-511

← 1 2 →